A citation-based method for searching scientific literature

Antonella Pietragalla, Simona Duranti, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Domenica Lorusso, Anna Fagotti, Giovanni Scambia. Expert Opin Investig Drugs 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.
Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R Madiyalakan, Yolanda D Mahnke, Christopher Nicodemus. Cancer Immunol Immunother 2020
9
100


MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.
Naoki Agata, Rehan Ahmad, Takeshi Kawano, Deepak Raina, Surender Kharbanda, Donald Kufe. Cancer Res 2008
60
100


O-glycosylation of the mucin type.
F G Hanisch. Biol Chem 2001
239
100


MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells.
Masaaki Yamamoto, Caining Jin, Tsuyoshi Hata, Yota Yasumizu, Yan Zhang, Deli Hong, Takahiro Maeda, Masaaki Miyo, Masayuki Hiraki, Yozo Suzuki,[...]. Cancer Res 2019
7
100

Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Tsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, Caining Jin, Rehan Ahmad, Yan Zhang, Ling Kui, Wei Li, Yota Yasumizu, Deli Hong,[...]. Mol Cancer Ther 2019
20
100

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
Jennifer A A Gubbels, Jennifer Belisle, Masanori Onda, Claudine Rancourt, Martine Migneault, Mitchell Ho, Tapan K Bera, Joseph Connor, Bangalore K Sathyanarayana, Byungkook Lee,[...]. Mol Cancer 2006
237
100

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
J F Liu, K N Moore, M J Birrer, S Berlin, U A Matulonis, J R Infante, B Wolpin, K A Poon, R Firestein, J Xu,[...]. Ann Oncol 2016
44
100

MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage.
Deepak Raina, Rehan Ahmad, Shailendra Kumar, Jian Ren, Kiyotsugu Yoshida, Surender Kharbanda, Donald Kufe. EMBO J 2006
71
100


MUC1 oncoprotein is a druggable target in human prostate cancer cells.
Maya Datt Joshi, Rehan Ahmad, Li Yin, Deepak Raina, Hasan Rajabi, Glenn Bubley, Surender Kharbanda, Donald Kufe. Mol Cancer Ther 2009
56
100

Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen.
Y Matsuoka, K Endo, Y Kawamura, T Yoshida, T Saga, Y Watanabe, M Koizumi, T Nakashima, J Konishi, N Yamaguchi. Cancer 1990
58
100

Cellular mucins: targets for immunotherapy.
V Apostolopoulos, I F McKenzie. Crit Rev Immunol 1994
115
100

Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients.
Lior Carmon, Irit Avivi, Riva Kovjazin, Tsila Zuckerman, Lillian Dray, Moshe E Gatt, Reuven Or, Michael Y Shapira. Br J Haematol 2015
33
100

Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125.
A G Zeimet, F A Offner, E Müller-Holzner, M Widschwendter, B Abendstein, L C Fuith, G Daxenbichler, C Marth. Tumour Biol 1998
33
100

MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope.
Pablo Argüeso, Sandra Spurr-Michaud, Cindy L Russo, Ann Tisdale, Ilene K Gipson. Invest Ophthalmol Vis Sci 2003
150
100


Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study.
Paul Sabbatini, Philipp Harter, Giovanni Scambia, Jalid Sehouli, Werner Meier, Pauline Wimberger, Klaus H Baumann, Christian Kurzeder, Barbara Schmalfeldt, David Cibula,[...]. J Clin Oncol 2013
83
100

The cancer antigen CA125 represents a novel counter receptor for galectin-1.
Claudia Seelenmeyer, Sabine Wegehingel, Johannes Lechner, Walter Nickel. J Cell Sci 2003
112
100

Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates.
Koita Sacko, Karthik Thangavel, Sunday A Shoyele. Nanomaterials (Basel) 2019
15
100

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2.
B Agrawal, M J Krantz, M A Reddish, B M Longenecker. Nat Med 1998
259
100

Immune surveillance of tumors.
Jeremy B Swann, Mark J Smyth. J Clin Invest 2007
806
100

MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, T Maeda, X Hu, D Adeegbe,[...]. Oncogene 2017
53
100

Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.
Yongqing Li, Derek Liu, Dongshu Chen, Surender Kharbanda, Donald Kufe. Oncogene 2003
167
100

MUC16: molecular analysis and its functional implications in benign and malignant conditions.
Dhanya Haridas, Moorthy P Ponnusamy, Seema Chugh, Imayavaramban Lakshmanan, Parthasarathy Seshacharyulu, Surinder K Batra. FASEB J 2014
56
100

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.
L D Roy, M Sahraei, D B Subramani, D Besmer, S Nath, T L Tinder, E Bajaj, K Shanmugam, Y Y Lee, S I L Hwang,[...]. Oncogene 2011
177
100

Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma.
Xin GongSun, YongQiang Zhao, Bin Jiang, ZhongWei Xin, Mo Shi, Liang Song, QiMing Qin, Qiang Wang, XiangYan Liu. J Cell Physiol 2019
11
100

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
Francesca Finotello, Clemens Mayer, Christina Plattner, Gerhard Laschober, Dietmar Rieder, Hubert Hackl, Anne Krogsdam, Zuzana Loncova, Wilfried Posch, Doris Wilflingseder,[...]. Genome Med 2019
121
100


Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines.
C Balagué, G Gambús, C Carrato, N Porchet, J P Aubert, Y S Kim, F X Real. Gastroenterology 1994
150
100

Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
Subhash C Chauhan, Ajay P Singh, Fernanda Ruiz, Sonny L Johansson, Maneesh Jain, Lynette M Smith, Nicolas Moniaux, Surinder K Batra. Mod Pathol 2006
106
100

MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
F Guddo, A Giatromanolaki, M I Koukourakis, C Reina, A M Vignola, G Chlouverakis, J Hilkens, K C Gatter, A L Harris, G Bonsignore. J Clin Pathol 1998
100
100

SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line.
Priyanka Grover, Sritama Nath, Monica D Nye, Ru Zhou, Mohammad Ahmad, Pinku Mukherjee. Oncotarget 2018
15
100

DNA Damage, Repair, and Cancer Metabolism.
Marc-Olivier Turgeon, Nicholas J S Perry, George Poulogiannis. Front Oncol 2018
80
100

Cancer-associated mucins: role in immune modulation and metastasis.
Rakesh Bhatia, Shailendra K Gautam, Andrew Cannon, Christopher Thompson, Bradley R Hall, Abhijit Aithal, Kasturi Banerjee, Maneesh Jain, Joyce C Solheim, Sushil Kumar,[...]. Cancer Metastasis Rev 2019
53
100

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial.
H J Gray, B Benigno, J Berek, J Chang, J Mason, L Mileshkin, P Mitchell, M Moradi, F O Recio, C M Michener,[...]. J Immunother Cancer 2016
18
100

Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1).
B C Schultes, R P Baum, A Niesen, A A Noujaim, R Madiyalakan. Cancer Immunol Immunother 1998
60
100

Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.
Keisuke Shigeta, Masanori Hasegawa, Eiji Kikuchi, Yota Yasumizu, Takeo Kosaka, Ryuichi Mizuno, Shuji Mikami, Akira Miyajima, Donald Kufe, Mototsugu Oya. Cancer Sci 2020
4
100



MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Hideaki Tsutsumida, Masamichi Goto, Shinichi Kitajima, Ichiro Kubota, Yasunobu Hirotsu, Joeji Wakimoto, Surinder K Batra, Kohzoh Imai, Suguru Yonezawa. Lung Cancer 2007
54
100

The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas.
Michael D Walsh, Joanne P Young, Barbara A Leggett, Stephanie H Williams, Jeremy R Jass, Michael A McGuckin. Hum Pathol 2007
48
100

Oregovomab maintenance monoimmunotherapy does not improve outcomes in advanced ovarian cancer.
Jonathan Berek, Peyton Taylor, William McGuire, L Mary Smith, Birgit Schultes, Christopher F Nicodemus. J Clin Oncol 2009
109
100

Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity.
J Hanaoka, K Kontani, S Sawai, M Ichinose, N Tezuka, S Inoue, S Fujino, I Ohkubo. Cancer 2001
26
100

CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.
Kaoru Akita, Minami Tanaka, Shuhei Tanida, Yugo Mori, Munetoyo Toda, Hiroshi Nakada. Eur J Cell Biol 2013
29
100


xCell: digitally portraying the tissue cellular heterogeneity landscape.
Dvir Aran, Zicheng Hu, Atul J Butte. Genome Biol 2017
643
100

Fundamentals of cancer metabolism.
Ralph J DeBerardinis, Navdeep S Chandel. Sci Adv 2016
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.